DOC · 10-Q · 2026Q3 · Full report
Financing Cash Flow Trends
HEALTHPEAK PROPERTIES, INC. · 2026-11-03 · Importance 77 · Surprise 82 · In source text
Net cash provided by financing activities increased $2.02 billion to $1.67 billion for the nine months ended September 30, 2026, compared with $353.4 million of net cash used in 2025. Inflows included Janus Living IPO and follow-on offering proceeds, Brookfield JV proceeds, higher net commercial-paper borrowings, and lower senior-note repayments. Offsets included higher distributions to noncontrolling interests, mortgage repayments, and common-stock repurchases, as well as lower senior-note issuance proceeds and fewer noncontrolling-interest contributions.
Key facts
- In July 2026, Healthpeak repaid $650 million principal amount of 3.25% senior unsecured notes with a 3.40% effective interest rate at maturity. source
- Net cash provided by financing activities was $1.671 billion for the nine months ended September 30, 2026, a $2.024 billion increase from 2025. source
- In January 2026, Healthpeak made a $102 million early full principal repayment of mortgage debt secured by two senior housing communities, originally maturing in December 2026. source
- In June 2026, Healthpeak repaid $142 million of mortgage debt secured by 13 outpatient medical buildings upon maturity. source
- Financing cash flow increased $2.0 billion for the nine months ended September 30, 2026, primarily from Janus Living offering proceeds, Brookfield JV proceeds, higher net commercial paper borrowings, fewer senior note repayments, and lower common dividends. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | negative | realized | -2.9% | In July 2026, Healthpeak repaid $650 million principal amount of 3.25% senior unsecured notes with a 3.40% effective interest rate at… |
| liability | positive | realized | +2.9% | In July 2026, Healthpeak repaid $650 million principal amount of 3.25% senior unsecured notes with a 3.40% effective interest rate at… |